Back to VA VANGUARD CAPITAL MANAGEMENT LLC

NGNENGNE
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in NEUROGENE INC

Yes. Vanguard Capital Management holds 536,525 shares of NGNE (Neurogene), worth $16.9M, as of its Q2 2026 13F filing. It increased the position by 21,798 shares (+4.2%) from Q1 2026. Vanguard Capital Management has held NGNE in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$16.9M

Current Shares

536,525

Total Value Change

+$6.5M

Total Shares Change

+21,798

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
536,525
+4.2%
$16.9M0.0%$31.45
29
2026-Q1
First report
514,727
-
$10.4M0.0%$21.99
0

Other major holders of NGNE: BlackRock, Inc., BlackRock Finance, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used